Less than 50 months after Greece crashed out of global debt markets, having brought Europe and its single currency to the brink of destruction and shaken American investment portfolios to the core, the tiny sun-splashed nation was shamelessly back on the world stage Thursday. Greece raised more than $4 billion with a new bond sale, purchased almost entirely by investors outside the country and at a relatively low payback rate of 4.75%. Investors had pledged almost seven times that amount to try to get a piece of the offering, according to Bloomberg News, citing a Greek government official.
The search for profit is difficult right now for investors. Interest rates in the U.S. and other major countries remain low following the global financial crisis of 2008 and early 2009. Stocks, especially in tech in the last year, have pushed new highs, at least until the last week. But the rush to buy Greek debt again is a clear sign of the absurdity of the bull market as it begins its sixth year.
Best Biotech Companies To Own For 2015: Myriad Genetics Inc (MYGN)
Myriad Genetics, Inc. (Myriad) is a molecular diagnostic company. The Company is focused on developing and marketing predictive medicine, personalized medicine and prognostic medicine tests. It performs all of its molecular diagnostic testing and analysis in its own reference laboratories. These technologies include the cornerstone technologies of biomarker discovery, high-throughput deoxyribo nucleuc acid (DNA) sequencing, ribo nucleic acid (RNA) expression and multiplex protein analysis. The Company uses this information to guide the development of new molecular diagnostic tests that are designed to assess an individual's risk for developing disease later in life (predictive medicine), identify a patient's likelihood of responding to drug therapy and guide a patient's dosing to ensure optimal treatment (personalized medicine), or assess a patient's risk of disease progression and disease recurrence (prognostic medicine).
As of June 30, 2012, the Company had launched nine commercial molecular diagnostic tests. The Company markets these tests through its own approximate 385-person sales force in the United States. The Company also markets its BRACAnalysis, COLARIS, and COLARIS AP tests through its own European sales force and have entered into marketing collaborations with other organizations in selected Latin American, European and Asian countries. The Company also generates revenue by providing companion diagnostic services to the pharmaceutical, and biotechnology industries and medical research institutions utilizing its multiplexed immunoassay technology.
Molecular Diagnostic Tests
The Company's molecular diagnostic tests are designed to analyze genes, their mutations, expression levels and proteins to assess an individual's risk for developing disease later in life, determine a patient's likelihood of responding to a particular drug, assess a patient's risk of disease progression and disease recurrence and measure a patient's exposure to drug therapy to ensu! re optimal dosing and reduced drug toxicity. The Company's BRACAnalysis test is a analysis of the BRCA1 and BRCA2 genes for assessing a woman's risk of developing hereditary breast and ovarian cancer. BRACAnalysis accounted for 81.7% of the Company's total revenue during the fiscal year ended June 30, 2012. Its The Company's COLARIS test is an analysis of the MLH1, MSH2, MSH6 and PMS2 genes for assessing a person's risk of developing colorectal cancer or uterine cancer.
The Company's COLARIS AP test detects mutations in the APC and MYH genes, which cause a colon polyp-forming syndrome known as Familial Adenomatous Polyposis (FAP), a more common variation of the syndrome known as attenuated FAP, and the MYH-associated polyposis signature (MAP). The Company's MELARIS test analyzes mutations in the p16 gene to determine genetic susceptibility to malignant melanoma. The Company's OnDose test is a nanoparticle immunoassay that is designed to assist oncologists in optimizing 5-FU (fluorouracil) anti-cancer drug therapy in colon cancer patients on an individualized basis. The Company's PANEXIA test is a comprehensive analysis of the PALB2 and BRCA2 genes for assessing a person's risk of developing pancreatic cancer later in life. The Company's PREZEON test is an immunohistochemistry test that analyzes the PTEN gene and assesses loss of PTEN function in many cancer types.
The Company's Prolaris test is a 46-gene molecular diagnostic assay that assesses whether a patient is likely to have a slow growing, indolent form of prostate cancer that can be safely monitored through active surveillance, or a more aggressive form of the disease that would warrant aggressive intervention, such as a radical prostatectomy or radiation therapy. The Company's TheraGuide 5-FU test analyzes mutations in the DPYD gene and variations in the TYMS gene to assess patient risk of toxicity to 5-FU (fluorouracil) anti-cancer drug therapy.
Companion Diagnostic Services and Other Revenue
! Through M! yriad RBM Inc., the Company provides biomarker discovery and companion diagnostic services to the pharmaceutical, biotechnology, and medical researches industries utilizing its multiplexed immunoassay technology. The Company's technology enables the Company to screen large sets of clinical samples from both diseased and non-diseased populations against the Company's menu of biomarkers. The Company's companion diagnostic services consist of Multi-Analyte Profile (MAP), Multiplexed Immunoassay Kits and TruCulture.
The Company has compiled a library of over 550 individual human and rodent immunoassays for use in its multi-analyte profile (MAP) testing services. The Company has also developed RodentMAP, a panel for use in pre-clinical animal studies and OncologyMAP, which measures cancer-related proteins to assists researchers accelerate the pace of discovery, validation and translation of cancer biomarkers for early detection, patient stratification and therapeutic monitoring. The Company has developed multiplexed immunoassay kits that enable its customers to leverage its technology services with their in-house capabilities. The Company's internally developed multiplexed immunoassay kits include all of the components necessary for a customer to perform a test on their own Luminex instrument. TruCulture is a simple, self-contained whole blood culture that can be deployed to clinical sites around the world for acquiring cell culture data without specialized facilities or training.
Advisors' Opinion:- [By Jake L'Ecuyer]
Shares of Myriad Genetics (NASDAQ: MYGN) got a boost, shooting up 15.63 percent to $31.42 after the company reported upbeat fiscal second-quarter results and lifted its revenue outlook for the year. Myriad also bought Crescendo Bioscience for $270 million.
- [By Jake L'Ecuyer]
Myriad Genetics (NASDAQ: MYGN) was also up, gaining 12.86 percent to $39.67 after the Centers for Medicare & Medicaid Services updated pricing for the sequencing of the BRCA1 and BRCA2 genes.
- [By Jake L'Ecuyer]
Myriad Genetics (NASDAQ: MYGN) was also up, gaining 13.04 percent to $39.74 after the Centers for Medicare & Medicaid Services updated pricing for the sequencing of the BRCA1 and BRCA2 genes.
- [By James E. Brumley]
Earlier this week, Roche Holding Ltd. (OTCMKTS:RHHBY) made big news by winning the FDA's approval to administer a breast cancer drug before surgical removal of a breast tumor ... the first time the Food and Drug Administration has believed surgery (then followed by drugs and chemo) wasn't the best approach. Earlier in the year, a company called Myriad Genetics, Inc. (NASDAQ:MYGN) made a big splash, helped along by celebrity Angelina Jolie, who - using a DNA test from the genetic-testing company - elected to undergo a double mastectomy because her diagnostic's scores she was at a greater risk of breast cancer. Aside from being good for MYGN and RHHBY shareholders, both Roche Holding and Myriad Genetics are doing good work for cancer patients (and pre-cancer patient) too. Yet, there's another smaller company close to entering the same breast cancer fight that made big news of its own today... MetaStat Inc. (OTCMKTS:MTST). Indeed, this off-the-radar company in many ways has more potential than Myriad or Roche do, just by the virtue and capability of its underlying science.
10 Best Integrated Utility Stocks To Invest In 2014: Nortech Systems Incorporated(NSYS)
Nortech Systems Incorporated operates as a contract manufacturing company. It manufactures wire harness cable and printed circuit board assemblies, electronic sub-assemblies, higher level assemblies, and complete devices. The company also provides value added services and technical support, including design, testing, prototyping, and supply chain management; and repair services on circuit boards used in machines in the medical industry. In addition, it engages in the design, manufacture, and post-production service of electronic and electromechanical medical devices for diagnostic, analytical, and other life-science applications. Nortech Systems Incorporated serves various industries that include aerospace and defense; medical; and the industrial markets, which include industrial equipment, transportation, vision, agriculture, and oil and gas. The company markets its products through sales force and independent manufacturers? representatives. Nortech Systems Incorporated was founded in 1981 and is headquartered in Wayzata, Minnesota.
Advisors' Opinion:- [By James E. Brumley]
In a perfect world stocks would move in predictable, manageable ways. We don't live - nor do we trade in - a perfect world. In the real world we have to adapt to and deal with the curve balls the market throws us, and there are no two stocks that illustrate that point better than Document Security Systems, Inc. (NYSEMKT:DSS) and Nortech Systems Incorporated (NASDAQ:NSYS) to today. While both NSYS and DSS are up today, one's overbought and ripe for a pullback, while the other is likely at the beginning of a trade-worthy rally.
10 Best Integrated Utility Stocks To Invest In 2014: WisdomTree Emerging Markets Equity Income Fund (DEM)
WisdomTree Emerging Markets High-Yielding Equity Fund (the Fund) seeks to track the performance of the WisdomTree Emerging Markets High-Yielding Equity Index (the Index). The Index measures the performance of emerging market stocks with relatively high dividend yields. The Index is created by selecting the top 30% of Index constituents ranked by dividend yield from the WisdomTree Emerging Markets Dividend Index. Companies eligible for inclusion in the Index must be incorporated in and have their shares listed on a major stock exchange in Argentina, Brazil, Chile, China, Czech Republic, Hungary, India, Indonesia, Israel, Malaysia, Mexico, the Philippines, Poland, Russia, South Africa, South Korea, Taiwan, Thailand or Turkey. Companies must have paid at least $5 million in cash dividends on their common stock in the 12 months prior to the most recent Index measurement date. Companies are weighted in the Index based on regular cash dividends paid. The Index includes large-capitalization, mid-capitalization and small-capitalization securities.
The Fund employs a passive management or indexing investment approach designed to track the performance of the Index. The Fund attempts to invest all, or substantially all, of its assets in the stocks that make up the Index. The Fund generally uses a representative sampling strategy to track the Index. The Fund�� investment advisor is WisdomTree Asset Management, Inc.
Advisors' Opinion:- [By Genia Turanova]
WisdomTree Emerging Markets Equity Income ETF (DEM) is designed to track the performance of the high-yielding subset of the dividend paying segment of 18 emerging-markets nations.
- [By Carlton Delfeld]
Finally, to get more Asia and emerging market exposure, add a dash of the WisdomTree Emerging Market Equity Income ETF (DEM).
DEM has 20% exposure to Taiwan, as well as 20% to Brazil. Telecom companies make up a majority of the companies in the basket and you can expect it to distribute dividend income in the area of 5% annually.
10 Best Integrated Utility Stocks To Invest In 2014: Alon USA Partners LP (ALDW)
Alon USA Partners, LP (Alon USA), incorporated on August 17, 2012, owns and operates refining and petroleum products marketing business. Its integrated downstream business operates primarily in the South Central and Southwestern regions of the United States. It owns and operates a crude oil refinery in Big Spring, Texas with total throughput capacity of approximately 70,000 barrels per day (bpd). The crude oil pipelines the Company utilizes consist of the Amdel, White Oil, Mesa Interconnect, Centurion and Centurion Interconnect. Its Big Spring refinery produces ultra-low sulfur gasoline, ultra-low sulfur diesel, jet fuel, petrochemicals, petrochemical feedstocks, asphalt and other petroleum products.
During the year ended December 31, 2011 and the six months ended June 30, 2012, sour crude, such as West Texas Sour (WTS), represented approximately 80.4% and 80.4% of its throughput, respectively, and sweet crude, such as West Texas Intermediate (WTI), represented approximately 15.8% and 17.1% of its throughput, respectively. For the year ended December 31, 2011 and the six months ended June 30, 2012, the Company produced approximately 49.1% and 49.2% gasoline, 32.3% and 32.5% diesel/jet fuel, 7.1% and 6.4% asphalt, 6.0% and 6.0% petrochemicals and 5.5% and 5.9% other refined products, in each case, respectively. The Company distributes fuel products through a product pipeline and terminal network of seven pipelines totaling approximately 840 miles and six terminals that it owns or access.
The Company competes with Chevron, ExxonMobil and Shell.
Advisors' Opinion:- [By Robert Rapier] In last week’s issue I discussed the basics of the refining sector. Today I will provide an overview of four MLPs that hold refining assets.
To review, the refining sector was very profitable in 2012 thanks to unusually high crack spreads, which for many US refiners are approximated by the price differential between Brent and West Texas Intermediate (WTI) crude oils. For a more thorough explanation of this phenomenon, please refer to last week’s issue.
After years of trading at a $1 to $3 per barrel discount to WTI, Brent began fetching a premium a few years ago as a glut of crude developed in the mid-continent area of the US. In 2011 the Brent-WTI price differential increased to more than $25/bbl, and it remained historically high in 2012.
But pipeline capacity started to catch up this year, and the share prices of refiners retreated as the glut began to dissipate and the Brent-WTI differential shrank. In Q3 2012, the Brent-WTI differential averaged $17.43/bbl, but by Q3 of this year, the differential had fallen to $4.43/bbl. This promises bad news for refiners about to report Q3 earnings.
Many analysts downgraded the refining sector in Q3, but as the differential fell below $5/bbl it was hard to imagine that the news could get much worse. With poor Q3 results largely priced in, the differential subsequently rose back above $10/bbl, signaling better refining margins moving into Q4.
Refiners began to post earnings this past week, and as expected they were weak. Valero (NYSE: VLO) reported slightly higher revenues year-over-year, but net earnings fell more than 50 percent from a year ago. Nevertheless, they beat the extremely pessimistic expectations of analysts, and Valero shares rose on the news.
Phillips 66’s (NYSE: PSX) refining unit actually posted a loss, but its chemical business turned in a solid quarter which more than compensated for the disappointing refining results.
The rest of the refine - [By Tom Dorsey]
Over a several day period, I submitted questions and Mr. Eisman, President, Chief Executive Officer and Director of Alon USA Energy Inc. (ALJ) and the parent company of Alon USA Partners LP Inc. (ALDW) responded. He provided some key insights to some challenges the company faces, where the company is going, and the opportunities available in the future. This insight should provide investors with additional information to understand the value of the company and the opportunity as an investor in the company.
- [By Robert Rapier]
I warned last week that refiners would report relatively poor earnings for Q3, and refinery MLPs could take a hit, presenting a buying opportunity. On Nov. 6 Alon USA Partners (NYSE: ALDW) reported a loss for the third quarter of $16.1 million, or ($0.26) per unit, compared with net income of $120.4 million for the same period last year. Paul Eisman, CEO and president, cited the deteriorating margins that I discussed in last week’s issue: “Our third quarter results were impacted by a volatile and deteriorating margin environment resulting primarily from decreasing discounts for West Texas crude oil.”
10 Best Integrated Utility Stocks To Invest In 2014: Consolidated Water Co. Ltd. (CWCO)
Consolidated Water Co. Ltd., through its subsidiaries, develops and operates seawater desalination plants and water distribution systems. It operates through three segments: Retail, Bulk, and Services. The Retail segment produces and supplies water to end-users, including residential, commercial, and government customers, as well as tourist properties. The Bulk segment supplies potable water to government utilities and private customers. The Services segment designs, constructs, and sells desalination plants to third parties, as well as provides desalination plant management and operating services to plants owned by others. The company uses reverse osmosis technology to produce fresh water from seawater. It operates approximately 14 reverse osmosis desalination plants in the Cayman Islands, The Bahamas, Belize, the British Virgin Islands, and the United States. Consolidated Water Co. Ltd. was founded in 1973 and is based in Grand Cayman, the Cayman Islands.
Advisors' Opinion:- [By Eric Volkman]
Consolidated Water (NASDAQ: CWCO ) is keeping its shareholder payout taps open. The company has declared a dividend of $0.075 per share for its Q3. This will be paid on July 31 to shareholders of record as of July 1. That amount matches each of the firm's previous quarterly distributions stretching back to late 2009. Prior to that, Consolidated Water handed out $0.065 per share.
- [By Garrett Cook]
Utilities shares gained around 0.83 percent in today’s trading. Meanwhile, top gainers in the sector included Consolidated Water Co (NASDAQ: CWCO), up 4.3 percent, CenterPoint Energy (NYSE: CNP), up 2.1 percent.
- [By David Dittman]
Question: Thanks for your input and the chat opportunity! Your long term thoughts on water stocks such as Companhia de Saneamento Basico do Estado de Sao Paulo (NYSE: SBS), known popularly as Sabesp, and Consolidated Water Co Ltd (NSDQ: CWCO)? I hold Aqua America Inc (NYSE: WTR) since your recommendation.
10 Best Integrated Utility Stocks To Invest In 2014: Motorcar Parts of America Inc. (MPAA)
Motorcar Parts of America, Inc., together wit its subsidiaries, remanufactures and distributes alternators and starters for import and domestic cars, light trucks, heavy duty, agricultural, and industrial applications in the United States and Canada. It replacement parts are used on vehicles after initial vehicle purchase. The company sells its products to approximately 12,000 retail outlets; automotive warehouse distributors; and OES customers under customer private labels and under the Quality-Built, Talon, Xtreme, and Reliance brand names. Motorcar Parts of America, Inc. was founded in 1968 and is based in Torrance, California.
Advisors' Opinion:- [By Lawrence Meyers]
Motorcar Parts of America (MPAA) is the tiniest entry at only a $208 million market cap. It�� a bit more specialized, focusing more on alternators, starters and wheel hub assemblies. It also distributes only through the DIY stores. MPAA sits on $100 million in debt and $16 million in cash. It’s cash flow negative and trades at a P/E of 14 on long term growth of 15%. I�� stay away from this one, given the cash flow situation.
- [By CRWE]
Motorcar Parts of America, Inc. (Nasdaq:MPAA) is scheduled to make a presentation on Wednesday, May 23, 2012 at 9:30 a.m. Pacific time at B. Riley & Company’s 13th Annual Investor Conference at the Loews Santa Monica Beach Hotel in Southern California.
10 Best Integrated Utility Stocks To Invest In 2014: Fleetcor Technologies Inc (FLT)
FleetCor Technologies, Inc. (FleetCor) is an independent global provider of specialized payment products and services to businesses, commercial fleets, oil companies, petroleum marketers and government entities in countries throughout North America, Latin America and Europe. During the year ended December 31, 2011, the Company processed more than 215 million transactions on its networks and third-party networks. The Company operates in two segments: North American and International segments. The Company provides its payment products and services in a variety of combinations to create payment solutions for its customers and partners. In August 2011, the Company acquired Mexican prepaid fuel card and food voucher business based in Mexico City, Mexico. On December 13, 2011, the Company acquired Allstar Business Solutions Limited, a fleet card company based in the United Kingdom. In July 2012, the Company acquired a Russian fuel card company. In July 2012, the Company acquired CTF Technologies, Inc.
The Company uses third-party networks to deliver its payment programs and services. In order to deliver its payment programs and services and process transactions, it owns and operates closed-loop networks through which it electronically connects to merchants and captures, analyzes and reports information. The Company also provides a range of services, such as issuing and processing. The Company markets its payment products directly to a range of commercial fleet customers, including vehicle fleets of all sizes and government fleets. Among these customers, it provides its products and services to small and medium commercial fleets. The Company also manages commercial fleet card programs for oil companies, such as British Petroleum (BP) (including its subsidiary Arco), Chevron and Citgo, and over 800 petroleum marketers.
The Company sells a range of fleet and lodging payment programs directly and indirectly through partners, such as oil companies and petroleum marketers. It provides it! s customers with various card products that function like a charge card to purchase fuel, lodging and related products and services at participating locations. The Company supports these cards with issuing, processing and information services that enable it to manage card accounts, facilitate the routing, authorization, clearing and settlement of transactions. The Company provides these services in a variety of outsourced solutions ranging from an end-to-end solution (consisting issuing, processing and network services) to limited back office processing services.
In addition, the Company offers a telematics solution in Europe that combines global positioning, satellite tracking and other wireless technology to allow fleet operators to monitor the capacity utilization and movement of their vehicles and drivers. The Company offers prepaid fuel and food vouchers and cards in Mexico that may be used as a form of payment in restaurants, grocery stores and gas stations. Approximately 10.4% of its revenue during the year ended December 31, 2011 came from its lodging and telematics products.
During 2011, the Company owns and operates eight closed-loop networks in North America and internationally. Fuelman network is the Company�� primary fleet card network in the United States. Corporate Lodging Consultants network (CLC) is the Company�� lodging network in the United States and Canada. The CLC Lodging network covers more than 17,700 hotels across the United States and Canada. Commercial Fueling Network (CFN) is the Company�� members only unattended fueling location network in the United States and Canada. Keyfuels network is the Company�� primary fleet card network in the United Kingdom.
CCS network is the Company�� primary fleet card network in the Czech Republic and Slovakia. Petrol Plus Region (PPR) network is the Company�� primary fleet card network in Russia, Poland, Ukraine, Belarus, Lithuania, Estonia and Latvia. Mexican network is the Company�� fuel! and food! card and voucher network in Mexico. Allstar network is the Company�� fleet card network in the United Kingdom. In the United States, the Company issues corporate cards that utilize the MasterCard payment network, which includes 176,000 fuel sites and 398,000 maintenance locations across the country. The networks of locations owned by the Company�� oil and petroleum marketer partners in both North America and internationally are utilized to support the card programs of these partners.
UNION TANK Eckstein GmbH & Co. KG (UTA) operates a network of over 46,000 fleet card-accepting locations across 38 countries throughout Europe, including more than 31,000 fueling sites. DKV operates a network of over 45,000 fleet card-accepting locations across 36 countries throughout Europe, including more than 30,500 fueling sites. In Mexico, the Company issues fuel cards and food cards that utilize the Carnet payment network, which includes approximately 8,700 fueling sites and 78,890 food locations across the country.
The Company competes with Wright Express Corporation, Comdata Corporation, U.S. Bank Voyager Fleet Systems Inc., Edenred and Sodexo, Inc.
Advisors' Opinion:- [By MONEYMORNING.COM]
That's why you would do well to take a look at FleetCor Technologies Inc. (NYSE: FLT). The company specializes in providing payment-processing services for businesses, commercial fleets, major oil companies, petroleum marketers, and government agencies.
- [By gurujx]
Fleetcor Technologies Inc. (FLT): President, Developing Markets Charles Richard Freund Sold 75,000 Shares
President, Developing Markets of Fleetcor Technologies Inc. (FLT) Charles Richard Freund sold 75,000 shares on 12/31/2013 at an average price of $116.07.
- [By Louis Navellier] Popular Posts: 3 ‘A’ Stocks to Buy – Are They Still Buys for the Third Quarter?3 Gold Mining Stocks Ready to Shine2 High-Profile Chinese Stocks to Sell Recent Posts: The Best Is Yet to Come for FleetCor (FLT) 2 High-Profile Chinese Stocks to Sell 3 Gold Mining Stocks Ready to Shine View All Posts The Best Is Yet to Come for FleetCor (FLT)
Editor�� note: This column is part of our Best Stocks for 2014 contest. Louis Navellier�� pick for the contest is FleetCor Technologies (FLT).
No comments:
Post a Comment